909 related articles for article (PubMed ID: 16110932)
1. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
Walters SJ; Brazier JE
Qual Life Res; 2005 Aug; 14(6):1523-32. PubMed ID: 16110932
[TBL] [Abstract][Full Text] [Related]
2. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.
Walters SJ; Brazier JE
Health Qual Life Outcomes; 2003 Apr; 1():4. PubMed ID: 12737635
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
[TBL] [Abstract][Full Text] [Related]
4. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
[TBL] [Abstract][Full Text] [Related]
5. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
7. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke.
Kim SK; Kim SH; Jo MW; Lee SI
Health Qual Life Outcomes; 2015 Mar; 13():32. PubMed ID: 25889191
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
[TBL] [Abstract][Full Text] [Related]
9. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
10. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
[TBL] [Abstract][Full Text] [Related]
11. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
[TBL] [Abstract][Full Text] [Related]
12. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
[TBL] [Abstract][Full Text] [Related]
14. EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy.
Xu RH; Lu M; Zhang S; Dong D
Eur J Health Econ; 2023 Nov; 24(8):1399-1410. PubMed ID: 36418784
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
van Stel HF; Buskens E
Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
[TBL] [Abstract][Full Text] [Related]
16. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
Boonen A; van der Heijde D; Landewé R; van Tubergen A; Mielants H; Dougados M; van der Linden S
Ann Rheum Dis; 2007 Jun; 66(6):771-7. PubMed ID: 17213254
[TBL] [Abstract][Full Text] [Related]
17. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
[TBL] [Abstract][Full Text] [Related]
18. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.
Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H
Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944
[TBL] [Abstract][Full Text] [Related]
19. [Health Utility of Patients with Stroke Measured by EQ-5D and SF-6D].
Du XD; Zhu P; Li ME; Wang J; Meng HD; Zhu CR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):252-257. PubMed ID: 29737071
[TBL] [Abstract][Full Text] [Related]
20. Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context.
Petrou S; Morrell J; Spiby H
Health Qual Life Outcomes; 2009 May; 7():40. PubMed ID: 19419553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]